Environment-dependent conformation and antimicrobial activity of a gramicidin S analog containing leucine and lysine residues  by Ono, Shin et al.
Volume 220, number 2, 332-336 FEB 05019 August 1987 
Environment-dependent conformation and antimicrobial 
activity of a gramicidin S analog containing leucine and 
lysine residues 
Shin Ono, Sannamu Lee, Yasushi Kodera*, Haruhiko Aoyagi, Michinori Waki, Tetsuo Kato and 
Nobuo Izumiya 
Laboratory of Biochemistry, Faculty of Science, Kyushu University 33, Higashiku, Fukuoka 812 and *Department of 
Chemistry, Faculty of Science, Fukuoka University, Fukuoka 814-01, Japan 
Received 30 June 1987 
An analog of gramicidin S, cyclo(-L-Leu-L-Lys-L-Leu-D-Leu-L-Leu-h, in which four out of five amino acid 
components of gramicidin S were substituted, has been synthesized. This analog assumes a conformation 
similar to that of gramicidin S in acidic liposomes and a random conformation i neutral liposomes. The 
antimicrobial ctivity of this analog corresponded to one-fourth of that of gramicidin S. A possible mecha- 
nism for conformational changes in acidic liposomes is discussed. 
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1. INTRODUCTION 
Gramicidin S (fig. 1) is a cyclic decapeptide anti- 
biotic exhibiting high inhibitory activity against 
Gram-positive bacteria [1]. Its decapeptide back- 
bone holds a rigid antiparallel d-sheet structure 
stabilized'by four intramolecular hydrogen bonds, 
two of which form two type II '  d-turns as shown 
in fig. 1. Structure-activity relationship and confor- 
mational studies with various gramicidin S analogs 
have shown that the amphiphilic property formed 
by the d-sheet and d-turn structure is necessary for 
antimicrobial activity [2]. Higashijima et al. [3] 
reported that the activity of gramicidin S analogs 
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correlated with the formation of a gramicidin S- 
like conformation upon binding to phospholipid 
membranes. Results of the studies on peptide-lipid 
interactions indicated that the activity of 
biologically active peptides correlates with the con- 
formation of the molecules in biological mem- 
branes rather than that in aqueous solution [4]. 
Considering these observations, we designed and 
synthesized a peptide assuming a gramicidin S-like 
conformation in lipid bilayers and expected it to 
exhibit biological activity. 
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Fig.1. Structure of gramicidin S. 
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Fig.2. Synthesis of the modified gramicidin S (1). 
We present here the synthesis and antimicrobial 
activity of a gramicidin S-like analog, cyclo(-L- 
Leu-L-Lys-L-Leu-D-Leu-L-Leu-)2 (1) in which the 
neutral amino acid residues in gramicidin S, name- 
ly L-valine, L-phenylalanine and L-proline, were 
replaced by leucine and the basic residue L- 
ornithine was replaced by L-lysine. We also show 
that compound 1 assumes a gramicidin S-like con- 
formation much more easily in acidic liposomes 
than in aqueous solution and neutral liposomes. 
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2. EXPERIMENTAL 
Dipalmitoyl-DL-phosphatidylcholine (DPPC) 
and dipalmitoyl-DL-phosphatidylglycerol (DPPG) 
were purchased from Sigma. 
Molecular mass was determined by fast atom 
bombardment mass spectroscopy (FAB-MS) on a 
JEOL JMS-DX 300 mass spectrograph with a 
JMA-3100 apparatus. CD spectra were recorded 
on a JASCO J-40A automatic recording spectro- 
polarimeter. ~H-NMR spectra in DMSO-d6 were 
Fig.3. ~H-NMR spectra of compound 1 in DMSO-d6 at 
90°C (a) and at 25°C (b). 
recorded on a JNM GX-400 spectrometer. Multi- 
lamellar vesicles were prepared as described 
previously [5]. 
The route for the synthesis of the modified 
gramicidin S analog 1 is shown in fig.2. The pep- 
tide chain was elongated stepwise by use of Boc- 
amino acid active ester and successive HCl-dioxane 
treatment until protected pentapeptide (2) was ob- 
Table 1 
Antimicrobial activity of gramicidin S and compound 1
Organism Minimum inhibitory 
concentration (/zg/ml) 
Gramicidin S 1 
Staphylococcus aureus FDA 209P 3. 
Staphylococcus aureus 308A-1 3. 
Bacillus subtilis PCI 219 3. 
Shigella flexneri EW- 10 3. 
Shigella sonnei EW-33 100 
Klebsiella pneurnoniae DT 25 
Escherichia coli NIHJ JC-2 > 100 
Proteus vulgaris IFO 3988 > 100 
Pseudomonas eruginosa U31 > 100 
13 
13 
13 
13 
12.5 
25 
25 
25 
>100 
100 
>100 
>100 
>100 
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Fig.4. Temperature d pendence of amide protons of the 
major conformer in compound 1 in DMSO-d6. 
tained. The pentapeptide 2 was converted to active 
ester (3), which was treated with TFA to obtain 
pentapeptide trifluoroacetate (4.TFA).  The 
4. TFA was subjected to cyclization in pyridine at 
3 mM 4. Purification by successive column 
chromatography on Amberlyst 15, Amberlyst 
A-27 and Sephadex LH-20 yielded a protected 
cyclic decapeptide (5) (18o70 from 4). Treatment of 
5 with 30% HBr in acetic acid afforded the desired 
compound 1.2HBr [98%, m.p. 249-252°C; Mr 
(m+ 1)+1162 by FAB-MS, calcd (m+ 1)+1161.9]. 
All crystalline compounds gave satisfactory 
elemental analyses. 
3. RESULTS 
Data of the antimicrobial assay are summarized 
in table 1. Compound 1 shows antimicrobial spec- 
tra similar to those of gramicidin S and has 
moderate activity, one-fourth to one-eighth of that 
of gramicidin S. 
~H-NMR spectra of 1 displayed overlapping 
signals in the amide and o~-proton regions showing 
the presence of one major and probably a few 
minor conformers at 25°C (fig.3b). Both protons 
showed one set of well-resolved signals at 90°C 
(fig.3a). This suggests that compound 1exists in an 
equilibrium of rapidly interconverting conformers 
at higher temperature. The temperature depend- 
ences of amide proton chemical shifts of the major 
conformer indicated that two NH protons with low 
temperature coefficients were solvent-shielded or 
hydrogen-bonded and three NH protons with high 
temperature coefficients were solvent-exposed 
(fig.4). The linear temperature dependences of all 
the NH chemical shifts indicate that the conformer 
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Fig.5. CD spectra of gramicidin S and compound 1in 20 mM Tris-HCl buffer (pH 7.4) (a) and in the presence of lipo- 
somes in the same buffer: DPPC ( . . . ) ;  DPPC-DPPG (3:1) ( ) and DPPC or DPPC-DPPG (3:1) ( - - - )  (b). 
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equilibrium of 1 does not change with tempera- 
ture. 
Fig.5 shows CD curves of gramicidin S and 1. 
characteristic feature (a double minimum of 
troughs at about 205 and 214 nm) for gramicidin 
S is essentially maintained for 1 in a buffer solu- 
tion at pH 7.4, though the intensity of the troughs 
decreased ramatically. In liposomes containing 
acidic phospholipid, the intensity of the double 
minimum of 1 is much higher than that in the buf- 
fer solution, though still less than that of 
gramicidin S. Interestingly compound 1 shows a 
random-like CD curve in neutral liposomes. On 
the other hand, CD curves of gramicidin S do not 
show any difference in buffer, neutral and acidic 
liposomes. 
4. DISCUSSION 
~H-NMR study shows that compound 1 assumes 
one major and a few minor conformations. The 
major conformation has two amide protons prob- 
ably participating in hydrogen bonding as shown 
by temperature-dependence xp riments. This sug- 
gests that 1 has four intramolecular hydrogen 
bonds like gramicidin S, if it assumes a C2 sym- 
metry structure. CD spectra suggest hat 1 assumes 
a gramicidin S-like conformation in buffer solu- 
tion, though the troughs are considerably more 
shallow than those of GS. In the presence of 
DPPC-DPPG liposomes (3: 1), the population of 
conformers having the gramicidin S-like confor- 
mation increased remarkably, indicating that the 
liposome induced the peptide to assume an amphi- 
philic structure by forming antiparallel d-sheet and 
type I I '  d-turn structures. Higashijima et al. [3] 
reported that the active peptide analogs of 
gramicidin S which interact with phospholipids ex- 
ist as a gramicidin S-like conformation in both 
neutral and acidic liposomes. However, compound 
1 does not assume gramicidin S-like conformation 
in neutral iposomes but does in acidic liposomes. 
These results mean that acidic liposomes interact 
with compound 1 to increase the gramicidin S-like 
conformation by charge interaction, while neutral 
liposomes interact with the peptide 1 to rupture the 
gramicidin S-like conformation which is present in 
buffer solution albeit in a low concentration. 
It is well-known that type II and type I I '  d-turns 
formed by the L-X-D-Y and D-X-L-Y sequences 
(X and Y are amino acid residues), respectively, 
have low energies of conformations [6]. Com- 
pound 1 is able to assume both d-turns by the se- 
quence of L-Lys-L-Leu-D-Leu-L-Leu or 
L-Leu-D-Leu-L-Leu-L-Leu. If  compound 1 
assumes a type II d-turn conformation, it is im- 
possible for compound 1 to form an effective am- 
phiphilic structure like gramicidin S because the 
basic amino acid and L-leucine residues direct to 
the same side of an antiparallel d-sheet. We 
previously reported that CD curves of type II and 
I I '  d-turns are characteristic and have a double 
minimum in the 201-206 nm and 215-223 nm 
region and a minimum in the region of about 
230 nm, respectively [7,8]. CD curves of 1 in buf- 
fer solution and neutral iposomes howed the dou- 
ble minimum due to the type I I '  /?-turn 
conformation. No troughs due to type II d-turn 
conformation were observed. The CD curve in 
neutral liposomes howed that compound 1 takes 
a random structure. A possible explanation is as 
follows: amphiphilic antiparallel d-structure is first 
induced through an electrostatic interaction with 
peptide and acidic liposomes, followed by forma- 
tion of type I I '  d-turn. On the other hand, charge 
interaction with cationic lysine residues in peptide 
and phospholipids in neutral iposomes is not as ef- 
fective as in acidic liposomes. Consequently, 
neither the antiparallel d-sheet structure is induced 
at the surface of neutral lipids nor the type I I '  d- 
turn conformation. 
Membranes of microorganisms contain acidic 
phospholipids. It is likely that compound 1 shows 
activity in cell membranes by assuming a 
gramicidin S-like conformation. 
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